Cagrilintide – 5 mg / 10 mg

Primary Benefits:

• Suppresses appetite by mimicking amylin

• Enhances satiety and reduces caloric intake

• Improves insulin sensitivity and metabolic health

• Complements GLP-1 agonists for synergistic fat loss

Mechanism of Action:
Cagrilintide is an amylin analogue that activates amylin receptors in the brain’s appetite-regulation centers. It slows gastric emptying, promotes feelings of fullness, and helps regulate postprandial glucose. It is often combined with GLP-1 receptor agonists for enhanced weight-loss efficacy.

Dosing & Protocol:

Subcutaneous (SQ) Injection using 30-31 gauge 6-8mm insulin syringe

• Reconstitution:
 – 5 mg vial → 2.0 ml bacteriostatic water
 – 10 mg vial → 2.0 ml bacteriostatic water

• Weekly Dose:
 – 5 mg vial → 250–500 mcg (10–20 units)
 – 10 mg vial → 250–500 mcg (5–10 units)

• Cycle:
 – Once weekly.
 – Begin with 250–500 mcg once per week for 4 weeks.
 – Then titrate up by 500-1000 mcg (0.5–1 mg) weekly, if needed.
 – Do not exceed 2500 mcg (2.5 mg) per week.

• Timing:

• Administer in the morning on the same day each week to maintain steady plasma levels.
• Take on the same day and time each week for stable blood levels.

Potential Side Effects:

• Mild nausea or fullness during the first few weeks

• Constipation or delayed gastric emptying

• Injection site irritation (rare)

• Not recommended for those with a history of pancreatitis

Common Stacks:

• With Tirzepatide or Semaglutide: Enhanced fat loss and appetite suppression

• With 5-Amino-1MQ: For metabolic acceleration and energy optimization

• With MOTS-c: For mitochondrial and endurance support

Notes:
Cagrilintide is most effective when used alongside dietary awareness and physical activity. It works best in combination with other peptide-based or GLP-1–based interventions. Store reconstituted vials in the refrigerator and discard after 30–45 days.

Disclaimer:
The information provided in this article is for educational and informational purposes only and is not intended as medical advice. These statements have not been evaluated by the FDA or Health Canada. Peptides and other compounds discussed are intended for research purposes only and are not approved for human consumption unless prescribed by a licensed medical professional. Always consult your healthcare provider before starting any new protocol, supplement, or treatment.